FindTrial
Sign In

Clinical study protocol for the diagnosis of extranodal nasal type NK/T cell lymphoma using 68Ga-FAPI and 18F-FDG PET

Clinical study protocol for the diagnosis of extranodal nasal type NK/T cell lymphoma using 68Ga-FAPI and 18F-FDG PET

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300074158
Enrollment
Unknown
Registered
2023-08-01
Start date
2023-04-27
Completion date
Unknown
Last updated
2023-08-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

extranodal nasal type NK/T cell lymphoma

Interventions

Gold Standard:The patient underwent nasopharyngoscopy examination and submitted the tissue for pathological analysis
Index test:Dual-tracer PET/CT with 18F-FDG and 68Ga-FAPI

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. ENKTL patients with initial diagnosis confirmed by pathology; 2. Age>18 years and without any other factors affecting the standard treatment plan; 3. The patient agree to perform 18F-FDG and 68Ga-FAPI PET/CT whole body scans and PET/MR local scans, and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Under the age of 18; 2. Diagnosed as central nervous system involvement and primary cutaneous T/NK cell lymphoma; 3. Having a history of other malignant tumors; 4. Having a history of chemotherapy/radiation therapy; 5. During pregnancy/lactation; 6. There is diabetes or fasting blood glucose is higher than 130mg/dL.

Design outcomes

Primary

MeasureTime frame
SUVmax;SUVmean;TBR;SUVmax difference;Sensitivity;Specificity;—

Secondary

MeasureTime frame
TLF;GTV;MTV;—

Countries

China

Contacts

Public ContactRong Tian

West China Hospital of Sichuan University

rongtiannuclear@126.com+86 189 8060 1586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026